AbbVie files a 72-page suit against HRSA over the 340B patient definition
Issue
AbbVie filed a 72-page complaint on April 8, 2026 in federal court in Washington, D.C., against HRSA, HHS and their leaders, targeting the 1996 340B patient definition. AbbVie argues the guidance lacks the force of law after the end of Chevron deference, as Axios reported.
A win would narrow which patients qualify and cut health center contract pharmacy revenue.
Sources for this story
AxiosPart of
- 340B drug pricing
AbbVie v. HRSA and the patient definition
Sources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
The newsletter is paused right now. Sign up and you will get it when it starts again.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
FQHC Talent. (2026, April 8). AbbVie files a 72-page suit against HRSA over the 340B patient definition. Source: Axios. Retrieved November 22, 2026, from https://www.fqhctalent.com/intel/abbvie-sues-hrsa-340b-patient-definition-april-2026